Patient Recruitment & Retention

Why use site networks when conducting clinical trials?

Site networks can enhance efficiency, reach, and quality

Sites are the cornerstone of successful patient recruitment and retention. Our support starts at site selection and continues throughout their clinical trial journey, from keeping sites informed via engaging and timely study communication to providing them with the tools, training and ongoing support to engage patients, healthcare professionals, and other stakeholders to maximize recruitment.

We provide site support through regular meetings or one-to-one coaching via our Clinical Enrollment partner. Where necessary on-site support can be provided, via our trusted partners, to cover staffing needs to either augment site capabilities or allow site staff to focus on patient care and get on with what they do best.

Why achieving diversity is challenging and why it’s important

Ensuring diversity among trial participants is essential as people of different ages, races, ethnicities, genders, and medical backgrounds may respond differently to treatments.

Achieving Diversity and Inclusion requires a multi-pronged comprehensive strategy.

• Allucent Site Intelligence carefully select sites with access to the desired patient demographic and have expertise in engaging them effectively
• Tailored diversity plans are synchronized with individual site strategies, ensuring we meet targets reliably and predictably.
• In-house patient education and information capabilities ensure effective communication with patients using language and imagery that connects with the patient and fosters trust

How can Patient Advocacy Groups help improve patient recruitment and retention?

Patient advocacy groups can be instrumental in bridging the gap between clinical researchers and participants

Patient Advocacy Groups (PAG) are diverse but critical stakeholders in supporting and engaging patients and their families across multiple therapeutic areas and can be particularly important in rare disease indications.

Allucent’s PAG engagement approach is designed to identify, engage and cultivate effective relationships with PAGs and is supported by our customized PAG onboarding process geared to minimizing administration for PAGs while taking the burden off our sponsors.

We support our sponsors in engaging with PAGs for the duration of the drug development cycle and beyond.

How do you increase patient participation in your clinical trial?

Educated patient participants are more likely to stay engaged and less likely to drop out if they have realistic expectations of processes and outcomes

• Allucent’s Patient Engagement team’s in-house graphics capabilities enable agile development of study-specific materials designed to engage patients, their families, participating sites, referring physicians, and other stakeholders in the patients’ healthcare community.
• We utilize our Patient Voice offering to enhance our understanding of the patient’s experience. This ensures that our messaging and imagery resonate fully with the target patient population.
• We can swiftly engage with “patient-like” individuals from the study population to explore all aspects of their disease experience and where they seek healthcare information, supporting the creation of customized, patient-centric engagement strategies.

Our services are developed quickly and cost-effectively to meet the needs of our sponsors.

What role can digital technology play in patient recruitment?

Digital technology plays a pivotal role in modernizing and increasing the access to clinical trials for participants

To increase access to clinical trials as a healthcare option we work with reliable and experienced digital partners who have considerable experience designing and executing digital recruitment campaigns that engage with patients and families where they seek healthcare information.

• Outreach is designed to resonate with and engage potential participants.
• Metrics are tracked to monitor the effectiveness of outreach efforts.
• Call-center warm hand-offs are used.
• Patients waiting are regularly engaged with to minimize leaks in the patient recruitment funnel.
• Care is taken to ensure that clinical sites are not overly burdened by an influx of patients.

Digital tools not only streamline recruitment but also open up opportunities for greater inclusivity and participant diversity in clinical research.